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Objectives: Diabetic foot ulcer (DFU) has been linked to high mortality and morbidity in 
diabetic patients. In spite of the increasing prevalence of diabetes and its complications, this 
issue has not been adequately studied in Iran.
Materials and methods: In this cross-sectional study we attempt to describe the prevalence 
of diabetic foot amputation in patients admitted to our training hospitals in Urmia, Iran, and 
also to determine the associated demographic, behavioral, and clinical factors.
Results: Of 94 patients with DFU, 34 (32%) had amputation. Those with amputation were 
  significantly older and were also less educated than those without amputation, had longer duration 
of diabetes (hence were more likely to suffer from complications), and had high-risk wounds 
plus a poor glycemic control. On logistic regression analysis two variables were associated 
with amputation: Wagner classification $3 and HbA1c. On a receiver operating characteristics 
curve, the HbA1c cutoff point of 9.7% significantly discriminated to predict increasing risk of 
amputation.
Conclusion: Both glycemic control and promoting the knowledge of patients and health care 
professionals in order to diagnose DFU in the early stages and to prevent development of the 
high-grade wounds would be a significant step in reducing the burden of DFU and its effect 
on quality of life in Iran.
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Introduction
Foot ulceration is one of the most serious and disabling complications of diabetes 
mellitus. It is the most common cause of nontraumatic foot amputation worldwide. 
Diabetic patients are 15 to 20 times more likely to require amputation than those with-
out the disease.1 The prevalence of diabetic foot ulcer (DFU) ranges from 4% to 10% 
in hospitalized patients. The risk of developing a foot ulcer in diabetic patients could 
be as high as 25% in their lifetime.2 Nearly 14%–24% of patients with DFU require 
amputation, which means that every 30 seconds a lower limb is lost because of   diabetes.1 
The Global Lower Extremity Amputation Study Group estimated that 25%–90% of 
all amputations were associated with diabetes.3 Diabetic foot amputation tends to 
be concomitant with a rise in mortality rates over time. The concomitant mortality 
is believed to be 13%–40% at 1 year, 35%–65% after 3 years, and 39%–80% after 
5 years.1 Treatment of DFU results in increased healthcare expenditures, prolonged 
hospital length of stay, and risk for amputation.1 In developed countries, more than 
5% of diabetic patients have DFU, the care for which consumes up to 20% of the total 
healthcare resources available for diabetes.4 In developing countries, not only does 
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the prevalence of DFU exceed that in developed countries 
but also DFU care devours as much as 40% of the available 
resources.4
Currently, the prevalence of diabetes in Iran is 7.7%, 
which is equivalent to 3 million cases when extrapolated to 
the Iranian population aged 25–64 years, with the prevalence 
of DFU estimated at 3%.1,5 This figure is expected to rise 
considerably by 2025.6
Several risk factors for amputation among patients with 
DFU have been cited in the literature, including age; sex 
(male); comorbidities or complications of diabetes such as 
hypertension, nephropathy, and retinopathy; having a previ-
ous history of DFU; and duration of diabetes.1,2,7–10
However, the validity of these findings in different cul-
tures and communities remains to be shown. Prediction of the 
outcome in patients with DFU might be helpful for clinicians 
in optimizing management strategy. Thus, we developed a 
cross-sectional study to describe the prevalence of amputa-
tion and to determine the associated demographic, clinical, 
and behavioral factors with amputation in hospitalized DFU 
patients in medical training settings. Clarifying these fac-
tors would lead to appropriate care and aid in preventing 
amputation.
Material and methods
This prospective cross-sectional study was conducted from 
September 2009 to December 2010. All diabetic patients with 
DFU admitted to two medical training hospitals (Taleghani 
and Imam) in Urmia, Iran, were enrolled into the study. The 
method of data collection was simple random sampling. 
The aim of the study was explained to all participants, and 
informed written consent was obtained from all. The Urmia 
University of Medical Sciences review board and ethics 
committee approved the study.
A questionnaire was used to collect data about clinical 
  status, such as type of diabetes, duration of diabetes, treatment 
category (insulin therapy, oral agents, and diet), presence 
of complications of diabetes according to medical records 
(including retinopathy, nephropathy, presence of comorbidity 
such as hypertension, ischemic heart disease, dyslipidemia), 
previous history of DFU, the length of hospitalization, 
baseline laboratory data (including HbA1c and blood sugar), 
grade of foot ulcer, and behavioral factors, including cur-
rent smoking (daily and occasional   smokers) and body 
mass index (BMI). Please note: foot ulcer was graded 
  according to Wagner’s classification: Grade 0,   high-risk foot; 
Grade 1, superficial ulcer; Grade 2, deep ulcer penetrating 
to tendon, bone, or joint; Grade 3, deep ulcer with abscess 
or osteomyelitis; Grade 4, localized   gangrene; and Grade 5, 
extensive gangrene requiring a major   amputation. BMI was 
divided into two categories: normal ,25 or overweight $25. 
Wounds were classified into two groups; Wegner grade #2 
were classified as low risk and grade $3 were classified as 
high risk.
Data regarding age, sex, educational level, and mari-
tal status (married, single, divorced, widowed) were also 
  collected in the same questionnaire.
Amputation was defined as the complete loss of the trans-
verse anatomical plan of any part of the lower limb.
Statistical analysis
Patients were divided into two groups: those who underwent 
major or minor amputation and those without amputation. All 
statistical analysis was performed using SPSS (version 12, 
SPSS, Inc, Chicago, IL). We used simple percentage to 
calculate the prevalence of amputation. We used the χ2 test 
for categorical variables and independent Student’s t-test for 
continuous variables. A P-value of less than 0.05 was consid-
ered significant. Logistic regression analysis was constructed 
to model the odds of amputation versus nonamputation. All 
variables were examined for the association with amputation, 
including sociodemographic factors (age, sex, education, 
marital status), behavioral factors (BMI and smoking), and 
clinical factors (duration of diabetes, treatment intensity, 
number of complications, and Wagner classification). We 
calculated odds ratios (OR) and 95% confidence intervals 
(CI) for all variables in the models.
A receiver operating characteristics curve was generated 
to determine the predictability of HbA1c and blood sugar 
levels at admission time for amputation. Sensitivity and 
specificity of cutoff point for blood sugar and HbA1c were 
also calculated.
Results
Of the 94 patients, 63.8% were men and the mean age was 
60.24 ± 11.5 years. More than half (57.4%) of the partici-
pants had a low education level (below high school). The 
mean BMI was 26.95 ± 3.3 and 60.6% of participants were 
overweight (BMI $ 25 kg/m2).
Most of the participants had diabetes type 2 (96.8%). 
Treatment category showed that 86.2% of participants were 
managed with an oral agent plus diet, and only 13.8% were 
on insulin alone or a combination of insulin and diet. Mean 
length of admission was 9.51 ± 5.3 days.
Eighty-four percent of patients reported having at least 
one complication of diabetes, eg, cardiovascular disease, 
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nephropathy, or retinopathy. A total of 20.2% of patients were 
on antilipid therapy. There was a high frequency of hyper-
tension (46.8%) and retinopathy (38.2%) when compared 
with other complications. Almost three-quarters (71.3%) of 
participants had a previous history of DFU. A total of 83% 
of patient wounds were classified as high risk (grade $3).
Prevalence of amputation  
and its associated factors
Of the 94 patients, 32 (34%) met the clinical criteria for 
  amputation. Compared with the group without   amputation, those 
with amputation were significantly older (68.15 ± 8.36 years 
vs 56.16 ± 10.88 years) (P-value = 0.000). Patients who were 
aged $50 years had a significantly higher risk of amputation 
than those aged #50 years (OR = 4.65, 95% CI: 1.22–5.51) 
(P-value = 0.007). The prevalence of amputation was the 
same in the males and females statistically.
Patients managed with amputation were less educated 
than those in the nonamputated group (25/32, 78.1% vs 29/62, 
46.8%, P-value = 0.009). There was a significant difference 
regarding marital status; a higher proportion of patients with 
amputation were not married (46.9%) compared with those in 
the nonamputation group (16.1%) (P-value = 0.01). Table 1 
represents demographic, behavioral, and clinical character-
istics in the amputation and nonamputation groups.
Clinical factors associated with amputation were dura-
tion of diabetes, having at least one complication, having a 
previous history of DFU, and BMI , 25. The mean dura-
tion of diabetes was 9.21 ± 6.03 years in the amputation 
group and 5.34 ± 3.21 years in the nonamputation group 
(P-value = 0.008). The average number of previous DFU 
was 3.46 ± 1.81 and 1.5 ± 1.04 times in the amputation 
and nonamputation groups, respectively (P-value = 0.000). 
Patients without amputation were more likely to be 
  overweight (OR = 2.7, 95% CI: 2.01–4.97) (Table 1).
Other clinical and behavioral factors such as treatment 
category, smoking, dyslipidemia, and ischemic heart disease 
had the same distribution in the amputation and nonamputation 
groups. Distribution of patients by Wagner ulcer classification 
showed grade $3 in 93.8% patients who underwent amputa-
tion, which was significantly different from the other group.
Comparison of diabetic complications revealed that retin-
opathy, nephropathy, and hypertension were more frequent 
among patients with amputation (Table 2).
Baseline laboratory data, including HbA1c and blood 
sugar at admission time, were significantly higher among 
patients who had amputation (Table 1).
Using logistic regression analysis and by excluding all 
confounders in the model, HbA1c $ 8% (OR = 4.2, 95% 
CI: 2.11–7.27) and high-risk wounds (OR = 6.4, 95% 
CI: 3.08–9.32) remained statistically significant regarding 
amputation.
Receiver operating characteristic curves were generated 
to determine the predictability of the levels of HbA1c and 
blood sugar at admission time for amputation (Figure 1).
A cutoff point of 9.75% for HbA1c and 305 g/dL showed 
75.2% specificity and 81.5% sensitivity for amputation. Area 
under the curve showed a value of 0.86 and 0.83 for HbA1c 
and blood sugar, respectively (P-value = 0.05).
Discussion
Management of the DFU by early education of the associated 
risk factors still remains a challenge in order to decrease the 
rate of amputation among DFU patients.
The overall prevalence of amputation in our setting 
was 34%. However, frequency of amputation was reported 
Table 1 Demographic, behavioral, and clinical features of diabetic foot ulcer (DFU) patients with and without amputation
P-value Nonamputation  
(n = 62)
Amputation  
(n = 32)
Variable
0.12 43/19 17/15 Sex (male/female) (no.)
0.000 56.16 (10.8) 68.15 (8.3) Age (mean [SD] years)
0.009 46.8 78.1 Low educational level (%)
0.01 16.1 46.9 Unmarried (%)
0.000 1.5 (1) 3.46 (1.8) Recurrent DFU (mean [SD] years)
0.03 46.8 25 Overweight (%)
0.36 48.4 46.9 Current smoker (%)
0.008 5.34 (3.1) 9.21 (6) Duration of diabetes (mean [SD] years)
0.001 75.8 100 Complications of diabetes (1+) (%)
0.32 11.3 18.8 Treatment intensity (insulin therapy) (%)
0.000 8.7 (2.1) 11.82 (2.0) HbA1c (mean [SD] years)
0.000 263.5 (79) 336.96 (64) Blood sugar (mean [SD] years)
0.000 51.9 77.1 Wagner classification $3 (%)
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Figure 1 Receiver operating characteristics (ROC) curve showing HbA1c and blood 
sugar (BS) in predicting overall amputation.
Table 2 Comparison of diabetic complications and comorbidities 
between groups with and without amputation
P-value Nonamputation  
(n = 62)
Amputation  
(n = 32)
Variables (%)
0.000 19.4 68.8 Retinopathy
0.002 35.5 68.8 Hypertension
0.000 8.1 50 Nephropathy
0.42 17 25 Dyslipidemia
0.47 15.6 12.9
in a wide range in several studies. Larijani et al11 reported 
that the rate of amputation dropped from 40% in 1995 to 
14% in 2001 and to less than 12% in 2007 with a mean 
length of hospitalization stay of 4 weeks. Another study in 
Iran in 2008 noted an amputation rate of 28.8% among DFU 
patients. The overall amputation rate was found to be 52.4% 
in Japan, 27.2% in Singapore, and 21.8% in China.3 Richard 
et al12 reported that 35% of the patients with DFU underwent 
lower limb amputation in France during hospitalization. High 
amputation rates might be due to the prevalence of disease 
in different settings, late presentation, inadequate resources, 
and a local approach by surgeons.13
Older patients are found to be less cooperative both physi-
cally and psychologically and to have a greater number of 
diabetic complications.6 In our study, amputation was more 
frequent in those patients with a lower educational level, who 
are unmarried, and of older age, which suggests an associa-
tion with social and financial factors.
The effect of gender on the frequency of DFU and amputa-
tion has been documented by many studies.1,14 The rate of ampu-
tation according to sex was about the same in our study.
Several studies showed that the duration of diabetes 
was correlated with higher risk of amputation,10,15,16 which 
is the same as in our study and in contrast with the report by 
Li et al,3 which found no relation between the duration of 
diabetes and the risk of amputation.
Meanwhile, insulin use was independently related to 
higher DFU occurrence and amputation.15,17,18 The category 
of treatment had no effect on amputation in our study.
Patients with at least one complication of diabetes and a 
previous history of DFU also had a higher risk of amputation 
in our study. There is also a large discrepancy between rate of 
amputation, comorbidities, and chronic complications of 
diabetes. Yesil et al10 have reported that the frequency of neph-
ropathy was lower in patients who underwent amputation. 
However, the frequency of hypertension,17 nephropathy, and 
retinopathy was higher with increasing risk of amputation.3,7–9 
Lipsky et al19 reported that there was a high association 
between lower extremity amputation and its risk factors.
Some of the previous studies have reported that the Wagner 
classification has a strong predictive factor for amputation,13,17,20 
which was also concluded by the results of our study.
Sohn et al21 reported a significant J-shaped association 
between BMI and DFU. As a matter of fact, obesity was a 
significant risk factor for developing microvascular compli-
cations.22 A survey of the effectiveness of foot care education 
in diabetic patients in Iran has concluded that obese patients 
referring to diabetic clinics need much more attention and 
better care programs.23 A BMI , 25 was significantly asso-
ciated with amputation in our study, which is the same as 
previously reported by Yesil et al.10 The energy consumption 
of the wound is higher during healing, due both to inflam-
matory cells and to the fibroblast production of collagen 
and matrix.24 This can explain malnutrition in patients with 
BMI , 25 and a consequent delay in healing of the wound 
or an increased risk of amputation.
Alcohol consumption and cigarette smoking are reported 
to be behavioral risk factors of amputation.2,10,15 There was 
no statistically significant difference between the number of 
smokers in amputation and nonamputation patients in our 
study, which was also reported by Li et al.3
The prevalence of diabetic microvascular complica-
tions and diabetic neuropathy is also reported to be higher 
in patients with poor glycemic control,22,25 whereas little 
research has demonstrated no correlation between HbA1c and 
risk of amputation.3,16 It is strongly shown that HbA1c was 
a significant risk factor for overall amputation in previous 
studies.7,9,26 According to our study, HbA1c is a predictive 
factor for risk of amputation, and the cutoff point for the risk 
is 9.2 (specificity 81% and sensitivity 87.5%).
One of the limitations of our study is that we evaluated 
the level of education and duration of diabetes based on 
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  self-reporting. Another limitation was to use medical records 
and drug history for verifying diabetic complications instead 
of clinical examination. These data came only from hospi-
talized patients, so outpatients with DFU who did not need 
amputation were not included in our study.
Conclusion
In summary, the fact that diabetes is a prevalent disease 
with an increasing incidence in Iran means that the rate of 
its complications such as DFU can be expected to soar in 
the future. Glycemic control and early diagnosis of DFU 
can be improved by increasing the knowledge of the patients 
and healthcare professionals to prevent the development of 
high-grade wounds, which would be a significant step in the 
collective effort to ease the burden of DFU in Iran.
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